Skip to main content
. 2019 Nov 11;140(25):2054–2062. doi: 10.1161/CIRCULATIONAHA.119.043826

Table 3.

Hemorrhagic Stroke, by Achieved LDL-C Category at 4 Months in Patients Assigned to Alirocumab Treatment

graphic file with name cir-140-2054-g005.jpg